DALK-AD with big bubble effective

Article

Deep anterior lamellar keratoplasties by air dissection (DALK-AD) using the big bubble (BB) technique provides good visual outcomes in keratoconus treatment.

Deep anterior lamellar keratoplasties by air dissection (DALK-AD) using the big bubble (BB) technique provides good visual outcomes in keratoconus treatment, reveals a study in Cornea.

Dr David Smadja et al., National Reference Centre for Keratoconus, Bordeaux University Hospital, France, performed 44 consecutive keratoplasties on 42 keratoconus patients between January 2008 to June 2010. The team analysed the outcomes of the DALK-AD that wasn't converted to penetrating keratoplasty and a learning curve was created to achieve DALK-AD using BB.

Of the DALK-AD procedures performed, 32 were successful and 12 were converted to penetrating keratoplasty during the surgical procedure. At 12 months follow-up mean best-corrected logarithm of the minimum angle of resolution visual acuity was 0.88 ± 0.14.

Best-corrected visual acuity of ≥20/30 was seen in 93.3% of patients and 100% achieved best-corrected visual acuity of ≥20/40. At six and twelve months follow-up the mean gain of visual acuity in logarithm of the minimum angle of resolution lines was 6.12 ± 3.97 and 6.94 ± 4.18, respectively.

The DALK-AD with BB is a safe and effective technique for the surgical treatment of keratoconus. However, surgeons will need a learning period to reduce intraoperative complications.

The abstract for this investigation can be found here .

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.